{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T18:11:42Z","timestamp":1760379102096,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T00:00:00Z","timestamp":1634342400000},"content-version":"am","delay-in-days":349,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100007543","name":"Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des Produits de Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ijantimicag.2020.106152","type":"journal-article","created":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T05:37:05Z","timestamp":1599370625000},"page":"106152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy of generic meropenem products in combination with colistin in carbapenemase-producing Klebsiella pneumoniae experimental osteomyelitis"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3617-5411","authenticated-orcid":false,"given":"P.","family":"Tattevin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Dinh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Ghout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Mouton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-C.","family":"Verdier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Lemaitre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Gatin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Saleh-Mghir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.-C.","family":"Cr\u00e9mieux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2020.106152_bib0001","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.molmed.2012.03.003","article-title":"Carbapenem resistance in Enterobacteriaceae: here is the storm!","volume":"18","author":"Nordmann","year":"2012","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.ijantimicag.2020.106152_bib0002","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.1128\/AAC.01019-15","article-title":"Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance","volume":"59","author":"Pitout","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.106152_bib0003","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cmi.2017.08.030","article-title":"Management of KPC-producing Klebsiella pneumoniae infections","volume":"24","author":"Bassetti","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2020.106152_bib0004","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.cmi.2018.01.015","article-title":"Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals","volume":"24","author":"Papst","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2020.106152_bib0005","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1128\/AAC.01222-13","article-title":"Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence","volume":"58","author":"Falagas","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.106152_bib0006","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/phar.2209","volume":"39","author":"Tsuji","year":"2019","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2020.106152_bib0007","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1128\/AAC.00350-13","article-title":"Even apparently insignificant chemical deviations among bioequivalent generic antibiotics can lead to therapeutic nonequivalence: the case of meropenem","volume":"58","author":"Agudelo","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.106152_bib0008","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1472-6904-10-3","article-title":"Comparative in vitro study of the antimicrobial activities of different commercial antibiotic products for intravenous administration","volume":"10","author":"Silva","year":"2010","journal-title":"BMC Clin Pharmacol"},{"issue":"Suppl 1","key":"10.1016\/j.ijantimicag.2020.106152_bib0009","first-page":"S217","article-title":"Monitoring of effectiveness and safety of generic formulation of meropenem for treatment of infections at Siriraj Hospital","volume":"94","author":"Angkasekwinai","year":"2011","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.ijantimicag.2020.106152_bib0010","first-page":"172","article-title":"Therapeutic effectiveness of a generic versus original meropenem in serious infections","volume":"94","author":"Tansuphasawadikul","year":"2011","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.ijantimicag.2020.106152_bib0011","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.medmal.2011.10.013","article-title":"Generic antibiotic drugs: is effectiveness guaranteed?","volume":"42","author":"Gauzit","year":"2012","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.ijantimicag.2020.106152_bib0012","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/cid\/cit769","article-title":"Efficacy and quality of antibacterial generic products approved for human use: a systematic review","volume":"58","author":"Tattevin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.106152_bib0013","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1093\/jac\/dkz257","article-title":"Efficacy of colistin alone and in various combinations for the treatment of experimental osteomyelitis due to carbapenemase-producing Klebsiella pneumoniae","volume":"74","author":"Cremieux","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2020.106152_bib0014","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ijantimicag.2019.07.009","article-title":"Colistin-containing cement spacer for treatment of experimental carbapenemase-producing Klebsiella pneumoniae prosthetic joint infection","volume":"54","author":"Gatin","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2020.106152_bib0015","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/infdis\/122.5.410","article-title":"Experimental osteomyelitis. I. A description of the model","volume":"122","author":"Norden","year":"1970","journal-title":"J Infect Dis"},{"year":"2011","series-title":"A language and environment for statistical computing","key":"10.1016\/j.ijantimicag.2020.106152_bib0016"},{"key":"10.1016\/j.ijantimicag.2020.106152_bib0017","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/bimj.200810425","article-title":"Simultaneous inference in general parametric models","volume":"50","author":"Hothorn","year":"2008","journal-title":"Biom J"},{"key":"10.1016\/j.ijantimicag.2020.106152_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","article-title":"Pharmacokinetic\/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men","volume":"26","author":"Craig","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.106152_bib0019","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1586\/14787210.2013.858600","article-title":"Recent advances in experimental models of osteomyelitis","volume":"11","author":"Cassat","year":"2013","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijantimicag.2020.106152_bib0020","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1128\/AAC.42.11.2830","article-title":"Efficacy of teicoplanin and autoradiographic diffusion pattern of [14C]teicoplanin in experimental Staphylococcus aureus infection of joint prostheses","volume":"42","author":"Saleh Mghir","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.106152_bib0021","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1086\/516135","article-title":"Experimental models of bone and prosthetic joint infections","volume":"25","author":"Cremieux","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.106152_bib0022","doi-asserted-by":"crossref","first-page":"e12837","DOI":"10.1111\/tid.12837","article-title":"Carbapenem-resistant Klebsiella pneumoniae vertebral osteomyelitis in a renal transplant recipient treated with ceftazidime\u2013avibactam","volume":"20","author":"Cani","year":"2018","journal-title":"Transpl Infect Dis"},{"issue":"2 Suppl","key":"10.1016\/j.ijantimicag.2020.106152_bib0023","first-page":"S163","article-title":"Osteomyelitis in military personnel wounded in Iraq and Afghanistan","volume":"64","author":"Yun","year":"2008","journal-title":"J Trauma"},{"key":"10.1016\/j.ijantimicag.2020.106152_bib0024","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jinf.2008.08.001","article-title":"Spinal infection caused by ESBL-producing Klebsiella pneumoniae treated with temocillin","volume":"57","author":"Barton","year":"2008","journal-title":"J Infect"},{"issue":"Suppl 3","key":"10.1016\/j.ijantimicag.2020.106152_bib0025","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1016\/j.ijid.2009.06.023","article-title":"Refractory vertebral osteomyelitis due to CTX-M-14-producing Escherichia coli at ertapenem treatment in a patient with a coexisting urinary tract infection caused by the same pathogen","volume":"14","author":"Lee","year":"2010","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.106152_bib0026","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1089\/mdr.2015.0006","article-title":"The use of therapeutic drug monitoring to optimize treatment of carbapenem-resistant Enterobacter osteomyelitis","volume":"21","author":"Stewart","year":"2015","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.ijantimicag.2020.106152_bib0027","doi-asserted-by":"crossref","first-page":"6291","DOI":"10.1128\/AAC.00926-12","article-title":"Ceftobiprole efficacy in vitro against Panton\u2013Valentine leukocidin production and in vivo against community-associated methicillin-resistant Staphylococcus aureus osteomyelitis in rabbits","volume":"56","author":"Saleh-Mghir","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.106152_bib0028","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2165\/10898530-000000000-00000","article-title":"Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysis","volume":"70","author":"Kesselheim","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2020.106152_bib0029","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1001\/jama.2008.758","article-title":"Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis","volume":"300","author":"Kesselheim","year":"2008","journal-title":"JAMA"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857920303514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857920303514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:37:41Z","timestamp":1760377061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857920303514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0924857920303514"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.106152","relation":{},"ISSN":["0924-8579"],"issn-type":[{"type":"print","value":"0924-8579"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of generic meropenem products in combination with colistin in carbapenemase-producing Klebsiella pneumoniae experimental osteomyelitis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.106152","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106152"}}